Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 37 for “"PNPLA3"”.

  1. Proteasome-Mediated Degradation of PNPLA3

    A missense mutation in PNPLA3 (148M) is the strongest genetic risk factor for fatty liver disease (FLD). PNPLA3 (148M) evades ubiquitylation and proteasomal degradation, and accumulates on hepatic lipid droplets (LDs). E3 Ubiquitin Ligases provides specificity to ubiquitin-mediated proteasomal …

    utswmed Repository record for Proteasome-Mediated Degradation of PNPLA3 (opens in a new tab)

  2. PNPLA3 P.I148M VARIANT INCREASES LIPID DROPLETS NUMBER AND SIZE IN PATIENT-DERIVED LIVER ORGANOIDS

    PNPLA3 rs738409 C>G p.I148M variant is the main genetic determinant of metabolic associated steatotic liver disease (MASLD). To this day, this association still lacks a molecular characterization, due to the lack of comprehensive human models. To overcome this gap in knowledge, we generated …

    milano Repository record for PNPLA3 P.I148M VARIANT INCREASES LIPID DROPLETS NUMBER AND SIZE IN PATIENT-DERIVED LIVER ORGANOIDS (opens in a new tab)

  3. NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology.

    … factor-15 (GDF-15) concentrations, PNPLA3-I148M genotype and altered adipose tissue (AT) biology. The aims of this thesis were to explore in patients with NAFLD, whether ≥F2 liver fibrosis associates with a) GDF-15, and whether GDF-15 concentrations influences the known association …

    soton Download PDF for NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology. (opens in a new tab)

  4. A Sirna-Based Targeted Therapy For Treating Metabolic Dysfunction-Associated Steatotic Liver Disease: A Precision Medicine Approach

    … patatin-like phospholipase domain containing 3 (PNPLA3) gene in MASLD and MASH is well established, with its single nucleotide polymorphism I148M being the single largest genetic risk factor for MASLD and MASH. The increased risk for MASLD attributed to the PNPLA3-148M allele relies on …

    wayne-thes Repository record for A Sirna-Based Targeted Therapy For Treating Metabolic Dysfunction-Associated Steatotic Liver Disease: A Precision Medicine Approach (opens in a new tab)

  5. Avaliação de polimorfismos dos genes PNPLA3, TM6SF2 e GCKR em pacientes com esteatohepatite metabólica submetidos a tratamento com probiótico

    … troca única (SNPs) envolvidos estão os dos genes PNPLA3, TM6SF2 e GCKR. Objetivo: Avaliar polimorfismos nos genes PNPLA3, TM6SF2 e GCKR em pacientes com MASH tratados com probiótico e sua relação com a resposta em marcadores antropométricos, bioquímicos e de inflamação hepática. Metodologia: …

    brazil-ufrgs Repository record for Avaliação de polimorfismos dos genes PNPLA3, TM6SF2 e GCKR em pacientes com esteatohepatite metabólica submetidos a tratamento com probiótico (opens in a new tab)

  6. Associação entre PNPLA3, TM6SF2 e nível de processamento de alimentos no risco de MASLD em pacientes na atenção primária à saúde

    … e a presença de polimorfismo de risco dos genes PNPLA3 e TM6SF2. Resultados: A média de idade dos pacientes foi de 58,0 ± 13,5 anos, sendo 71,8% mulheres. A estimativa de presença de esteatose na população avaliada através do FLI (FLI≥30) foi de 39,7%. Em 59,6% dos casos, NFS indicou risco médio …

    brazil-ufrgs Repository record for Associação entre PNPLA3, TM6SF2 e nível de processamento de alimentos no risco de MASLD em pacientes na atenção primária à saúde (opens in a new tab)

  7. Translational genomics, transcriptomics and metabolomics analyses of the metabolic effects of chronic hepatitis C infection and their clinical implications

    … significant predictors of SVR. Host IL28B and PNPLA3 polymorphism are significant host determinants of susceptibility to hepatic steatosis in chronic HCV G1 infection. Lower PNPLA3 genotype frequency in African American (AA) patients may explain their lower frequency of hepatic steatosis …

    unsw Repository record for Translational genomics, transcriptomics and metabolomics analyses of the metabolic effects of chronic hepatitis C infection and their clinical implications (opens in a new tab)

  8. Symptoms, genetics, and health-related quality of life in persons with nonalcoholic fatty liver disease

    … risk of disease progression based on <italic>PNPLA3 </italic> (rs738409) genotype. <bold>Methods: </bold> A cross-sectional descriptive design, guided by the symptoms experience model, was used to recruit 42 persons 21 years of age or older with diagnosed NAFLD from gastroenterology and …

    msu Repository record for Symptoms, genetics, and health-related quality of life in persons with nonalcoholic fatty liver disease (opens in a new tab)

  9. Informing the Development of a Culturally-Sensitive, Genotype-Informed Intervention for Treatment of Nonalcoholic Fatty Liver Disease in Mexican-Origin Women

    … polymorphism, rs738409, occurring in the PNPLA3 gene, which represents an Ile148Met substitution (C>G). This allele confers a substantially greater susceptibility to NAFLD and various stages of progressive NAFLD, including risk and severity of cirrhosis and hepatocellular carcinoma. In the …

    arizona-thes Repository record for Informing the Development of a Culturally-Sensitive, Genotype-Informed Intervention for Treatment of Nonalcoholic Fatty Liver Disease in Mexican-Origin Women (opens in a new tab)

  10. Οι πολυμορφισμοί των programmed cell death-1 (PD-1) rs 11568821, interleukin -28B (IL28B) rs12979860 και patatin-like phospholipase domain- containing protein 3 (PNPLA3) rs 738409 στην αυτοάνοση ηπατίτιδα

    … been studied in autoimmune liver diseases. The PNPLA3 rs738409 (I148M) polymorphism has been associated with hepatic steatosis and progressive fibrosis in several chronic liver diseases apart MASLD. Limited available data support its role as a disease modifier in autoimmune liver disease as …

    greece Repository record for Οι πολυμορφισμοί των programmed cell death-1 (PD-1) rs 11568821, interleukin -28B (IL28B) rs12979860 και patatin-like phospholipase domain- containing protein 3 (PNPLA3) rs 738409 στην αυτοάνοση ηπατίτιδα (opens in a new tab)

  11. Μελέτη φαρμακογενετικών πολυμορφισμών σε παιδιατρικούς ασθενείς με οξεία λεμφοβλαστική λευχαιμία (ΟΛΛ)

    … τις οποίες μελετώνται πολυμορφισμοί στα γονίδια PNPLA3 & NFATC2. Η παρούσα έρευνα μελετά τους πολυμορφισμούς rs1142345 (TPMT*3C), rs116855232 (NUDT15), rs1801133 (MTHFR), rs738409 (PNPLA3), rs1800462 (TPMT*2), rs1800460 (TPMT*3B), rs11045879 (SLCO1B1), rs6021191 (NFATC2) συσχετιζόμενους με πιθανή …

    athens Repository record for Μελέτη φαρμακογενετικών πολυμορφισμών σε παιδιατρικούς ασθενείς με οξεία λεμφοβλαστική λευχαιμία (ΟΛΛ) (opens in a new tab)

  12. Effect of omega-3 fatty acids in non-alcoholic fatty liver disease

    … phospholipase domain-containing protein-3 (PNPLA3 I148M) and the transmembrane 6 superfamily member 2 protein (TM6SF2 E167K), on the level of DHA and EPA enrichment and end of study liver fat percentage after DHA+EPA treatment; and c) the effect of fatty acid desaturase (FADS) and Elongase …

    soton Download PDF for Effect of omega-3 fatty acids in non-alcoholic fatty liver disease (opens in a new tab)

  13. THE MBOAT7 AND TM6SF2 GENETIC REPLENISHMENT RESCUES THE MITOCHONDRIAL DYNAMICS IN IN VITRO NAFLD MODELS AND OPENS A SPYHOLE TOWARDS MITOCHONDRIAL BIOMARKERS FOR NON-INVASIVE NAFLD DIAGNOSIS

    … Patatin-like Phospholipase Domain-containing 3 (PNPLA3), the rs641738 in the Membrane bound O-acyltransferase domain containing 7-transmembrane channel-like 4 (MBOAT7-TMC4) locus, and the E167K Transmembrane 6 Superfamily Member 2 (TM6SF2) polymorphisms represent the main predisposing factors to …

    milano Repository record for THE MBOAT7 AND TM6SF2 GENETIC REPLENISHMENT RESCUES THE MITOCHONDRIAL DYNAMICS IN IN VITRO NAFLD MODELS AND OPENS A SPYHOLE TOWARDS MITOCHONDRIAL BIOMARKERS FOR NON-INVASIVE NAFLD DIAGNOSIS (opens in a new tab)

  14. Estudio de las características fenotípicas y genotípicas en pacientes con hígado graso no alcohólico con sobrepeso vs.obesidad

    … (SNP): the genetic variant I148M of PNPLA3 and G308G of TNF-α in a sample of patients with NAFLD with overweight and obesity, comparing these factors in both population subgroups. MATERIAL AND METHODS: This is an observational, cross-sectional and descriptive study on a prospective …

    valladolid Repository record for Estudio de las características fenotípicas y genotípicas en pacientes con hígado graso no alcohólico con sobrepeso vs.obesidad (opens in a new tab)

  15. Non-invasive diagnosis of non-alcoholic fatty liver disease.

    … patatin-like phospholipase domain containing 3 (PNPLA3), transmembrane 6 superfamily 2 (TM6SF2) and fibroblast growth factor 21 (FGF21) variants as well as a panel of most abundant liver microRNAs. After univariate and multivariate analysis, we confirmed that GG genotype of PNPLA3 exerted a clear …

    sevilla Repository record for Non-invasive diagnosis of non-alcoholic fatty liver disease. (opens in a new tab)

  16. Genetische, lipidomische und radiologische Merkmale der Nicht-alkoholischen Fettlebererkrankung im Kindes- und Jugendalter

    … evaluiert. Hier wurde die Bedeutsamkeit der PNPLA3 148M Risikovariante sowohl für die Entwicklung der NAFLD als auch für den histologischen Schweregrad bei Kindern und Jugendlichen bestätigt. In der Untersuchung lipidomischer Profile aus dem Lebergewebe zeigte sich eine positive Assoziation …

    fu-berlin Repository record for Genetische, lipidomische und radiologische Merkmale der Nicht-alkoholischen Fettlebererkrankung im Kindes- und Jugendalter (opens in a new tab)

  17. ASSOCIAZIONE TRA SCORE GENETICO GRS E RISCHIO DI EPATOCARCINOMA IN PAZIENTI CON CIRROSI HCV TRATTATI CON FARMACI ANTIVIRALI DIRETTI

    … score (GRS) based on the combination of 4 SNPs (PNPLA3 rs738409, MBOAT7 rs641738, TM6SF2 rs5842926 and GCKR rs1260326) and HCC in a cohort of DAA-treated patients. Methods: Consecutive HCV cirrhotics receiving DAA between December 2014-2016 in a single Center were genotyped for the 4 SNPs. …

    milano Repository record for ASSOCIAZIONE TRA SCORE GENETICO GRS E RISCHIO DI EPATOCARCINOMA IN PAZIENTI CON CIRROSI HCV TRATTATI CON FARMACI ANTIVIRALI DIRETTI (opens in a new tab)

  18. Prevalencia, severidad y costes asociados al diagnóstico de pacientes con esteatosis hepática metabólica (EHmet)

    … as well as the genetic polymorphisms of PNPLA3, TNF-alpha and CNR1, which are also associated with more severe forms of the disease. Non-invasive methods allow diagnosis in most patients. Although liver biopsy is still necessary in some cases, it doubles the cost associated with the care …

    valladolid Repository record for Prevalencia, severidad y costes asociados al diagnóstico de pacientes con esteatosis hepática metabólica (EHmet) (opens in a new tab)

  19. Non - alcoholic fatty liver disease: role of genetic and environmental factors

    … loci were selected. Genotypes for PNPLA3 rs738409, TM6SF2 rs58542926, GCKR rs780094 and MBOAT7 rs641738 were extracted from a genome-wide single nucleotide polymorphism (SNP) database. Main Results: We replicated the effect of previously reported contributors to NAFLD likelihood in …

    greece Repository record for Non - alcoholic fatty liver disease: role of genetic and environmental factors (opens in a new tab)

Page 1 of 2